Resources

Type of publications
Regions
Diseases

5255 results found

2022 ∙ Dinas, P. C. Koutedakis, Y. Ioannou, L. G. Metsios, G. Kitas, G. D.

Effects of Exercise and Physical Activity Levels on Vaccination Efficacy: A Systematic Review and Meta-Analysis

  • Adolescents
  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ghazy, R. M. Ashmawy, R. Hamdy, N. A. Elhadi, Y. A. M. Reyad, O. A. Elmalawany, D. Almaghraby, A. Shaaban, R. Taha, S. H. N.

Efficacy and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Li, X. Yang, X. Ning, Z.

Efficacy and safety of COVID-19 inactivated vaccine: A meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Zhang, L. Jiang, L. Tian, T. Li, W. Pan, Y. Wang, Y.

Efficacy and Safety of COVID-19 Vaccination in Older Adults: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Graña, C. Ghosn, L. Evrenoglou, T. Jarde, A. Minozzi, S. Bergman, H. Buckley, B. S. Probyn, K. Villanueva, G. Henschke, N. Bonnet, H. Assi, R. Menon, S. Marti, M. Devane, D. Mallon, P. Lelievre, J. D. Askie, L. M. Kredo, T. Ferrand, G. Davidson, M. Riveros, C. Tovey, D. Meerpohl, J. J. Grasselli, G. Rada, G. Hróbjartsson, A. Ravaud, P. Chaimani, A. Boutron, I.

Efficacy and safety of COVID-19 vaccines

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
2022 ∙ Toubasi, A. A. Al-Sayegh, T. N. Obaid, Y. Y. Al-Harasis, S. M. AlRyalat, S. A. S.

Efficacy and safety of COVID-19 vaccines: A network meta-analysis

  • Adolescents
  • Adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Graña, C. Ghosn, L. Evrenoglou, T. Jarde, A. Minozzi, S. Bergman, H. Buckley, B. S. Probyn, K. Villanueva, G. Henschke, N. et al.,

Efficacy and safety of COVID‐19 vaccines

  • Children
  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Moderate
2022 ∙ Efros, O. Anteby, R. Halfon, M. Meisel, E. Klang, E. Soffer, S.

Efficacy and Safety of Third Dose of the COVID-19 Vaccine among Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Rinaldi, I. Pratama, S. Wiyono, L. Tandaju, J. R. Wardhana, I. L. Winston, K.

Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Han, C. L. Yan, Y. C. Yan, L. J. Meng, G. X. Yang, C. C. Liu, H. Ding, Z. N. Dong, Z. R. Hong, J. G. Chen, Z. Q. Li, T.

Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades

  • All age groups
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...